Likewise, the therapeutic benefits of AGE are mediated by the inhibition of pancreatic β-cell apoptosis, which subsequently causes an increase in serum levels of insulin, suggesting AGE as a viable alternative therapeutic approach for combating DM. The gene discussed is INS; the disease is diabetes mellitus.